mak et al-2012-alimentary pharmacology & therapeutics
TRANSCRIPT
-
8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics
1/11
-
8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics
2/11
INTRODUCTION
Dyspepsia is a common gastrointestinal condition that is
characterised by chronic recurrent epigastric symptoms
such as pain, burning and postprandial symptoms. Dys-
pepsia is associated with signicant functional impair-
ment and burden on healthcare resources.1 Estimates of
community prevalence of dyspepsia have varied widely
from 5% to 40%2 depending on criteria used. Yet,
community prevalence measured using strictly applied
Rome III criteria,3 which are more precise and restrictive
than their predecessors, remains sparse.4
It has been reported that comorbid psychiatric disor-
ders are common in patients with dyspepsia. Generalised
anxiety disorder (GAD) and Major depressive episodes
(MDE), in particular, have been most extensively related
to dyspepsia. These three disorders share several
commonalities. Similar to functional dyspepsia, both
GAD and MDE are typically chronic and relapsing, more
common in female, with onset and exacerbation oftenassociated with psychosocial stress.5, 6 Moreover, visceral
hypersensitivity and somatisation have been associated
with all three conditions.4, 7 – 10
Studies have found increased anxiety and depressive
symptoms on rating scales,11 and poorer psychological
wellbeing 12 in organic and functional dyspepsia. How-
ever, their relevance to how specic comorbid mental
disorders may contribute to the clinical and societal
burden of dyspeptic symptoms12 remains unclear. As
effective interventions exist for mental disorders,
their treatment may benet the clinical outcome of dyspepsia.13
To date, most studies on psychiatric correlates in dys-
peptic patients came from referral centres and clinics.4
Selection bias may distort any association of psychiatric
morbidity and dyspepsia found in these samples, because
only 25 – 42%14 of dyspepsia sufferers in the community
seek medical care. It is unclear whether psychological
distress may motivate or hinder patients in seeking care
for dyspeptic symptoms. The recent community-based
Kalixanda study 15 evaluated the relationship between
anxiety, depression and functional dyspepsia. It foundanxiety, but not depression, to be associated with func-
tional and organic dyspepsia. However, the Rome III
criteria used in this study were post hoc rated from a
Rome II questionnaire with the Rome III 6-month onset
criterion discarded. Meanwhile, HADS, as with most
psychiatric symptom scales, captured symptoms as a
dimensional score, and did not meet the duration
and impairment requirements for diagnosis of GAD
and MDE as mental disorders dened by the American
Psychiatric Associations’ Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition- Text
Revision (DSM-IV-TR)16 (Tables 2 and 3). Using the
Structured Clinical Interview for DSM-IV Axis-I
Disorder (SCID-I),17 we found 38.2% and 16.4% of
Chinese patients in a tertiary gastroenterology clinic with
functional dyspepsia to have an anxiety disorder and
depressive disorder respectively.18
We therefore set out to conduct a community survey
to examine the current community prevalence of strin-
gently dened Rome III Dyspepsia (Table 1), as well as
the 12-month prevalence of GAD and MDE using
DSM-IV-TR. We also evaluated the association between
dyspepsia, GAD and MDE and the chronological
relationship of their onsets. Although rarely examined
in previous studies, the latter may shed light on
whether these illnesses may be causally related to each
other.19
METHODS
A random community-based telephone survey of the
general population in the age range of 15 – 65 years was
conducted from 22nd April to 13th May, 2009. The
study was approved by the research ethics committee of
The Chinese University of Hong Kong. The Hong Kong
Institute of Asia-Pacic Studies of the Chinese University
of Hong Kong, an independent survey research organisa-
tion, was commissioned to conduct the survey. Inter-
viewers were university students with 1 – 3 years of
part-time experience in telephone interviews. A brieng session was held by the investigators (AM, JW, YC) for
training of administration of the questionnaire and
explaining skills involved in eliciting symptoms of dys-
pepsia, GAD and MDE. Respondents were invited to
take part in a telephone survey of ‘digestive problems
and emotional health’. Interviews proceeded only after
verbal consent was sought. The interviews were
conducted in Cantonese dialect, the predominant spoken
Table 1 | Rome III symptomatic criteria for functionaldyspepsia
3
Must include
One or more of
a Bothersome postprandial fullness
b Early satiation
c Epigastric pain
d Epigastric burning
Criteria fullled for the last 3 months with symptom onset at
least 6 months before diagnosis.
Aliment Pharmacol Ther 2012; 36: 800-810 801ª 2012 Blackwell Publishing Ltd
Community study on dyspepsia, depression and anxiety
-
8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics
3/11
-
8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics
4/11
MDE (Tables 2 and 3) based on DSM-IV-TR Criteria
and healthcare utilisation.
The same questionnaire for GAD and MDE diagnoses
had been used in previous series of telephone surveys
that found 12-month prevalence of GAD to be 4.1%22
and 8.4% for major depressive episode (MDE).23 Clinical
re-appraisal for diagnoses of MDE and GAD using the
gold standard of psychiatric diagnosis in research, the
Table 3 | Survey questions pertaining to the DSM IV-TR symptoms of major depressive episode
DSM – IV criteria Questions in the telephone survey
Required response for
diagnosis
FIVE or more of the following in the same
2 week period, representing a change from
previous functioning. At least ONE should
be either (1) or (2)1. Depressed mood most of the day, nearly
every day (reported or observed)
2. Markedly diminished interest or pleasure
in (almost) all activities most of the day,
nearly every day (reported or observed)
3. Signicant weight loss
4. Insomnia or hypersomnia nearly every
day
5. Psychomotor agitation or retardation
nearly every day (observed + subjective)
6. Fatigue or loss of energy nearly every day
7. Feelings of worthlessness or excessive or
inappropriate guilt nearly every day (not
merely self-reproach or guilt about beingsick)
8. Diminished ability to think or
concentrate, or indecisiveness, nearly
every day (subjective or objective)
9. Recurrent thoughts of death (not just fear
of dying), recurrent suicidal ideation
without a specic plan, or a suicide
attempt or a specic plan for committing
suicide.
A1. In the past year, have you had 2 weeks
or longer when you had depressed mood
most of the day, nearly every day?
A2. In the past year, have you had 2 weeksor longer when you had markedly reduced
interest or pleasure in almost all activities
most of the time, nearly every day?
‘Yes’ in A1 or A2
B. During the period when you had
(depressed mood) (reduced interest or
pleasure), did you often have
a Poor appetite or lost weight
b Slept less than usual
c Observable slowing of speech or actions
d Fatigue or loss of energy
e Difculty to concentrate or make
decisions
f Observable restlessness and agitation
g Increased appetite or body weight
h Slept more than usual
i Felt worthless
j Thoughts of death or suicide
a and g counted as 1
item
b and h counted as 1
item
c and f counted as 1
item
‘Yes’ in at least FIVE
items in sections A and
B, including at least one
item in A.
D. Clinically signicant distress or
impairment in social, occupational/other
important areas of functioning
D1. Did the above experiences cause you
signicant distress? AND/OR
‘Very distressed’ or
‘Quite distressed’ AND/
OR
D. Clinically signicant distress orimpairment in social, occupational/other
important areas of functioning
D2. Did the above experiences signicantlyimpair your daily life (e.g. study/work,
social & family life?
‘Very impaired’ or ‘Quiteimpaired’
Aliment Pharmacol Ther 2012; 36: 800-810 803ª 2012 Blackwell Publishing Ltd
Community study on dyspepsia, depression and anxiety
-
8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics
5/11
Structured Clinical Interview for DSM-IV Axis-I Disor-
ders (SCID-I) yielded good agreement.24, 25 The same
series of telephone survey had assessed prevalence of Rome III Irritable Bowel Syndrome in Hong Kong to be
5.4%, comparable while conservative, with overseas esti-
mates.26
We also asked ‘how much did you spend over the past
5 years on investigations for your gastrointestinal
problems?’ to assess investigation expenditure and ‘how
frequently did you see a doctor for your health problems’
to assess frequency of consultations. Subjects were also
asked for each disorder their respective ages when the
disorder rst came on in their lives so as to estimate
chronological association of the disorders.
Study power
Power calculation was performed post hoc based on the
sample collected to estimate the size of odds ratio that
can be detected in the whole sample and the dyspepsia
subgroup. With an overall sample (n = 2011), a logistic
regression of binary response variable of dyspepsia
(n = 142, 7% dyspepsia without MDE) on the binary
independent variable of GAD (n = 77, 3.8%), to
achieve 80% power at a signicance level of 0.05, will
have a minimum detectable odds ratio of 2.60. For
the dyspepsia-only subgroup (n = 161), for logistic
regression of binary response variable of GAD (n = 4,
4% GAD without MDE) on the binary independent vari-
able of MDE (n = 53, 33%), the minimum detectable
odds ratio would be 5.24, to achieve 80% power at a sig-
nicance level of 0.05.27
Analysis
The current prevalence of dyspepsia and 12-month prev-
alence of generalised anxiety disorder and major depres-
sive episode were presented as percentages. The study
sample was weighted (Appendix S1) according to age and
sex distribution of the Hong Kong general population
based on the 2008 Census data (Table 4). To identify
Phone calls made withvalid telephone numbers
(n = 6378)
No suitable respondent(n = 720)
n = 3793
Interview refused by otherfamily members (n = 931)
n = 2862
n = 2142
Hung up immediately(n = 2585)
n = 2093
Failure to contactsuitable respondent (n = 49)
Successfully interviewedrespondents n = 2011
Refused by suitablerespondent (n = 82)
Figure 1 | Flow diagram depicting various reasons for
and number of subjects who did not participate in the
study.
Table 4 | Sociodemographic characteristics of the
respondents and comparison with Hong Kong Census
data
Total sample
(n = 2011), % (n)
% Census
2008*
Gender
Male 46.6 (937) 47.2
Female 53.4 (1074) 52.8
Age
15 – 24 16.9 (341) 17.0
25 – 34 20.4 (411) 20.4
35 –
44 22.5 (454) 22.645 – 54 24.3 (488) 24.2
55 – 65 15.8 (317) 15.8
Education
Primary or below 11.3 (317) –
Secondary 45.2 (905) –
Pre college 10.3 (206) –
College or above 33.3 (667) –
Work status
Employed 60.6 (1212) –
Unemployed 6.4 (129) –
Retired 7.0 (141) –
Student 12.1 (241) –
Homemaker 13.8 (278) –
Marital statusSingle 38.4 (769) –
Married/living together 59.4 (1190) –
Previously married 2.1 (43) –
Income level
HKD 10 000 20.8 (389) –
HKD 10 000 – 30 000 46.6 (869) –
HKD 30 000 – 60 000 22.3 (416) –
HKD 60 000 10.3 (192) –
* Data from Hong Kong Census and Statistics Department,
2008.
804 Aliment Pharmacol Ther 2012; 36: 800-810ª 2012 Blackwell Publishing Ltd
A. D. P. Mak et al.
-
8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics
6/11
factors independently associated with dyspepsia, Chi-
squared tests were used in the whole sample to explore
the association of the psychiatric diagnoses and sociode-
mographic variables with dyspepsia. All diagnostic and
sociodemographic variables were then entered into logis-
tic regression (enter mode, without any elimination) with
dyspepsia. Multivariate analysis did not proceed in the
dyspepsia sub-group due to insuf cient sample size.
Logistic regression and ordinal regression were used to
examine factors independently associated with high
investigation expenditure [arbitrarily dened as spending
HKD50000 (equivalent to USD6427) or more on investi-
gations over the previous 5 years], frequent medical con-
sultations (arbitrarily dened as monthly or more
frequent medical consultations) and their respective asso-
ciation with all diagnostic and sociodemographic vari-
ables. Statistical analyses were performed using the
Statistical Package for Social Studies, Version 16.0 (SPSS
Inc., Chicago, IL, USA). All P values were two-tailedwith the level of statistical signicance specied at 0.05.
RESULTS
Prevalence and sociodemographic prole
Of the 2011 respondents, 8.0% (n = 161) currently ful-
lled Rome III criteria for dyspepsia. Among these
respondents, 81.3% (n = 131) had postprandial distress
syndrome (PDS), 7.5% (n = 12) had epigastric pain syn-
drome (EPS), 4.3% (n = 7) had both PDS and EPS,
while 14.9% (n = 24) was unclassied (Table 5). Allthese subjects reported dyspeptic symptoms that were
occurring more than once a week with onset at least
6 months ago. Amongst all sociodemographic variables,
only lower levels of education were signicantly associ-
ated with dyspepsia. There was also a nonsignicant
trend of high prevalence of dyspepsia in female.
(Table 4).
The 12-month prevalence of GAD was 3.8% (n = 77).
The 12-month prevalence of MDE, at 12.4% (n = 249),
has been reported before.28
Comorbidities of dyspepsia
Dyspepsia was signicantly associated with both GAD
and MDE; 21.3% of respondents with MDE met Rome
III criteria for dyspepsia vs. 6.1% of non-MDE respon-
dents (P < 0.001). 32.9% of dyspeptic respondents vs.
10.6% of nondyspeptic respondents met criteria for
MDE (P < 0.001) (Table 6).
In all 24.3% of GAD respondents had dyspepsia vs.
7.3% of non-GAD respondents (P < 0.001); 11.8% of
dyspepsia respondents also had GAD, vs. 3.1% of non-
dyspepsia respondents (P < 0.001) (Table 6).
In the multivariate analysis that included all sociodemo-
graphic correlates, the adjusted odds ratio of GAD being associated with dyspepsia was 2.03 (95% CI: 1.06 – 3.89,
P = 0.03), while the adjusted OR of MDE being associated
with dyspepsia was 3.56 (95% CI: 2.33 – 5.43, P < 0.001).
Comorbidities of PDS and EPS
Generalised anxiety disorder was found in 10.6%
(n = 14) of PDS [vs. 3.4% (n = 63) non-PDS, P < 0.001]
respondents and 16.7% (n = 2) of EPS [vs. 3.8%
(n = 75) non-EPS] respondents. MDE was found in
34.4% (n = 45) of PDS respondents [vs. 10.9% (n = 204)
non-EPS] and 25% (n = 3) of EPS [vs. 12.3% (n = 246)non-EPS] respondents.
Concomitant MDE and GAD
Having concomitant MDE and GAD was associated with
higher prevalence of comorbid dyspepsia than having
only one or none psychiatric diagnosis; 28.3% (n = 15)
of respondents with both GAD and MDE had dyspepsia
(P < 0.001), vs. 19.2% (n = 42) with a single psychiatric
diagnosis (P < 0.001), and 6.0% (n = 104) in those with-
out psychiatric comorbidity. On multivariate analysis,
having both GAD and MDE was signicantly associatedwith higher prevalence of dyspepsia (Adjusted
OR = 6.65, 95% CI: 3.35 – 13.21, P < 0.001) than having
one psychiatric diagnosis (Adjusted OR = 3.62, 95% CI:
2.37 – 5.51, P < 0.001) and no psychiatric comorbidity.
Chronological relationship in the onset time of
dyspepsia, GAD and MDE
In all, 28.6% of respondents with dyspepsia reported rst
onset of dyspeptic symptoms before age of 20. Current
Table 5 | Prevalence of dyspepsia and its subgroups,
GAD and MDE
Prevalence,
% (n)
Dyspepsia (Rome III) 8.0 (161)
Postprandial distress syndrome 81.3 (131)
Epigastric pain syndrome 7.5 (12)Psychiatric diagnoses
Generalised anxiety disorder 3.8 (77)
Major depressive episode 12.4 (249)
Number of psychiatric diagnoses
No psychiatric diagnosis 86.5 (1739)
One psychiatric diagnosis (GAD OR MDE) 10.9 (219)
Two psychiatric diagnoses (GAD and MDE) 2.6 (53)
Aliment Pharmacol Ther 2012; 36: 800-810 805ª 2012 Blackwell Publishing Ltd
Community study on dyspepsia, depression and anxiety
-
8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics
7/11
comorbidity with GAD was not signicantly associatedwith early onset of dyspeptic symptoms (33.3% dyspeptic
respondents with comorbid GAD vs. 31.3% without co-
morbid GAD, P = 1.0), nor was MDE comorbidity
(31.4% MDE-comorbid vs. 31.9% non-MDE-comorbid
dyspeptic respondents, P = 1.0).
For respondents with dyspepsia and MDE, 44.5%
reported concomitant onset of the two disorders, 31.5%
reported earlier onset of depression than dyspepsia, while
24% reported onset of dyspepsia before depression. For
GAD-dyspepsia comorbid respondents, up to half (54%)of the respondents reported concomitant onset of the
disorders, while 26.7% reported having dyspepsia rst,
19.3% having GAD rst. The vast majority (89.4%) of
those with both GAD and MDE reported concomitant
onset of GAD and MDE, while 7.8% and 2.8% of those
had GAD and MDE rst respectively.
To further examine the effect of order of onset of dys-
pepsia and mental disorders on occurrence of dyspepsia,
prevalence of dyspepsia was compared between subjects
Table 6 | Sociodemographic characteristics and psychiatric comorbidity in dyspeptic respondents
Dyspepsia
(n = 161), % (n) Crude OR P Adjusted OR P
Gender
Male 6.9 (75) 1 1
Female 8.9 (86) 1.32 (0.95 – 1.83) 0.10 1.16 (0.78 – 1.80) 0.47
Age 0.6215 – 24 7.9 (27) 0.90 (0.51 – 1.56) 0.70 1.04 (0.36 – 3.02) 0.95
25 – 34 7.1 (29) 0.79 (0.46 – 1.37) 0.40 0.90 (0.43 – 1.88) 0.77
35 – 44 6.8 (31) 0.78 (0.46 – 1.34) 0.37 0.78 (0.40 – 1.53) 0.47
45 – 54 9.6 (47) 1.12 (0.68 – 1.84) 0.65 1.18 (0.64 – 2.18) 0.60
55 – 65 8.5 (27) 1 – 1 –
Education 0.27
Primary or below 10.2 (23) 1.87 (1.09 – 3.19) 0.02* 1.51 (0.72 – 3.12) 0.27
Secondary 9.1 (82) 1.61 (1.09 – 2.40) 0.02* 1.58 (0.99 – 2.53) 0.06
Pre college 7.2 (15) 1.24 (0.67 – 2.31) 0.50 1.08 (0.54 – 2.15) 0.83
College or above 5.8 (39) 1 – 1 –
Work status 0.89
Employed 7.6 (92) 0.74 (0.47 – 1.15) 0.18 0.88 (0.51 – 1.53) 0.27
Unemployed 8.5 (11) 0.85 (0.41 – 1.76) 0.66 0.87 (0.39 – 1.95) 0.74
Retired 5.7 (8) 0.55 (0.25 –
1.24) 0.15 0.60 (0.23 –
1.60) 0.31Student 7.9 (19) 0.77 (0.42 – 1.41) 0.39 0.82 (0.28 – 2.39) 0.72
Homemaker 10.1 (28) 1 – 1 –
Marital status 0.94
Single 7.5 (58) 1 – 1 –
Married/living together 8 (95) 1.08 (0.77 – 1.52) 0.66 0.95 (0.57 – 1.60) 0.85
Previously married 14 (6) 1.93 (0.77 – 4.83) 0.16 1.11 (0.39 – 3.15) 0.85
Income level 0.88
HKD 10 000 9.5 (30.4) 1.44 (0.75 – 2.76) 0.28 0.89 (0.41 – 1.87) 0.73
HKD 10 000 – 30 000 7.9 (69) 1.17 (0.83 – 2.15) 0.62 0.84 (0.43 – 1.65) 0.62
HKD 30 000 – 60 000 6.5 (27) 0.95 (0.48 – 1.88) 0.88 0.75 (0.37 – 1.54) 0.44
HKD 60 000 6.8 (13) 1 – 1 –
Psychiatric diagnoses
GAD
No GAD
24.3 (19)
7.3 (142)
4.10 (2.37 – 7.08)
-
8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics
8/11
with onset of mental disorders (GAD or MDE) preced-
ing dyspepsia (To allow comparison, this group also
comprised those with only mental disorders now, based
on the assumption of future onset of dyspepsia) and
those where onset of mental disorders did not precede
dyspepsia. Dyspepsia was not more common in those
with mental disorders preceding dyspepsia (7.7%) com-
pared with those where mental disorders did not precede
dyspepsia (8.0%, P = 0.87). On multivariate analysis that
included all other sociodemographic factors, the associa-
tion of precedent-onset mental disorders with dyspepsia
remained insignicant (Adjusted OR = 0.83 95% CI:
0.47 – 1.45, P = 0.51).
Frequent medical consultations
Frequent medical consultations were, on univariate analy-
sis, less common amongst male (M 10.9% vs. F 17.3%,
P < 0.001) and students. It was more common amongst
homemakers (Employed 14.9%, unemployed 14.1%,retired 17.1%, students 5%, homemakers 18.8%; P = 0.04).
Respondents with dyspepsia made signicantly more
frequent medical consultations than those with no dys-
pepsia (31.7% vs. 12.8%, P < 0.001). GAD and MDE
were also associated with more frequent medical consul-
tations (36.8% GAD vs. 13.5% non-GAD, P < 0.001;
30.4% MDE vs. 12.1% non-MDE, P < 0.001). Using
multivariate analysis, dyspepsia (Adjusted OR = 2.48,
95% CI: 1.65 – 3.72 P < 0.001), MDE (Adjusted
OR = 2.39, 95% CI: 1.64 – 3.46, P < 0.001), female gender
(Adjusted OR = 1.65, 95% CI: 1.21 –
2.23, P < 0.001)were all found to be independent predictors of frequent
medical consultations.
High investigation expenditure
In all, 14% of dyspeptic respondents vs. 9.4% of nondys-
peptic respondents spent moderately [dened as more
than HKD10000 (equivalent to USD 1289) on medical
investigations over the past 5 years]. 3.2% dyspeptic vs.
1.3% nondyspeptic respondents had high investigation
expenditure [dened as spending more than hkd 50 000
(equivalent to USD 6449) on medical investigations overthe past 5 years]. There was a statistically nonsignicant
trend of dyspepsia being associated with high investiga-
tion expenditure (P = 0.06). GAD (5.6% vs. 1.3%,
P = 0.003), but not MDE (2.5% vs. 1.3%, P = 0.16),
was associated with high investigation expenditure on
univariate analysis. GAD was the only signicant
predictor of high investigation expenditure on multivari-
ate analysis (Adjusted OR = 4.65, 95% CI: 1.15 – 18.70,
P = 0.03).
DISCUSSION
We set out to determine the current prevalence of
dyspepsia with stringent Rome III symptom criteria in a
random, representative Chinese community sample.
Participation rate was comparable to previous telephone
health surveys.26 We observed that dyspepsia was
strongly associated and often had coincident onset with
GAD and MDE in the community.
Direct comparisons for community prevalence of
Rome III dyspepsia are sparse. Our conservative gure
was, possible cross-national variation aside, consistent
with the Rome III restrictiveness.3 Omission of the
6-month onset requirement from Rome III criteria may
explain the high prevalence of 20% in the Kalixanda
study.15 We found dyspepsia slightly more common in
females, as in local and overseas data.14, 15 Our GAD
prevalence and sociodemographic correlates were consis-
tent with extant community data, which were also
similar to Western ndings and a previous identically designed survey in Hong Kong.26 The 12.4% MDE
prevalence, reported previously, was higher than the
2007 gure of 8.5%, probably related to the 2008 global
nancial crisis.28
We found signicant and independent association of
dyspepsia with GAD and MDE as mental disorders. This
is consistent with the reported association of anxiety
symptoms with dyspepsia.4, 15 The link with depression
is more controversial. While we found a strong associa-
tion between MDE and dyspepsia, even higher than that
for GAD, the Kalixanda study found anxiety but notdepression to be associated with dyspepsia.15 This may
be due to the inclusion of dyspepsia of shorter duration
in the Kalixanda study, which may have a weaker associ-
ation with depression than anxiety. In addition, the
HADS depression subscale comprises only symptom
scores over 1 week ’s duration and had no requirement
for functional impairment, and therefore it was substan-
tially less accurate than DSM-IV-TR MDE, which
required 2 weeks of depressive symptoms causing signi-
cant functional impairment or marked distress (Table 3).
Nonetheless, signicant association between dyspepsiaand depressive symptoms was noted in a previous local
community survey using HADS and Rome II,14 as well
as a meta-analysis.4 Future surveys on psychiatric com-
orbidity using standard diagnostic assessment will help
clarify the relationship between dyspepsia and depres-
sion.
GAD and MDE were both more common in PDS,
while only GAD was signicantly more common in EPS.
In view of the small sample size, between-group
Aliment Pharmacol Ther 2012; 36: 800-810 807ª 2012 Blackwell Publishing Ltd
Community study on dyspepsia, depression and anxiety
-
8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics
9/11
comparison would not be meaningful and as such should
be examined in larger community samples.
Particularly salient was the nding that GAD and MDE,
as mental disorders each having distinct biological and
environmental aetiologies, were associated with dyspepsia.
While cross-sectional studies map chronology poorly, our
preliminary ndings were that most of the comorbid sub-
jects had coincident onset of mental disorders and dyspep-
sia, and that preceding mental disorders were not a
signicant risk factor for dyspepsia. Coincident-onset thus
appears to be the predominant mode of comorbidity. This
disputes the assertion of distress from dyspepsia itself
totally explaining its association with depressive and anxi-
ety features. It is also against the view of mental disorders
‘causing ’ dyspepsia. Rather, the nding is consistent with
neurophysiological ndings that autonomic nervous sys-
tem and hypothalamo-pituitary-adrenal axis derange-
ments typical of anxiety disorders and depressive
disorders29 may alter gastrointestinal function.30 It alsoconcurs with evidence that onset of dyspeptic symptoms
‘behaves’ similarly as anxiety and depressive disorders as
systemic reactions to major stressful life events.31 This
strong association between dyspepsia, GAD and MDE
implies that mental disorders should be routinely screened
during the assessment of patients with dyspepsia.
The stepwise increase in risk of dyspepsia with
increased number of psychiatric diagnoses mirrors
evidence from the psychosomatic literature that supports
a dose-response link between somatic symptom load and
psychopathology.32 Studies with larger samples anddetailed severity measures should conrm whether
dyspeptic symptoms could predict level of psychiatric
morbidity in a proportionate manner. Methodologically,
this stresses the value of including both anxiety and
depressive disorders when studying psychiatric comor-
bidity of medical disorders.
Psychiatric comorbidity seemed to have a complex
impact on healthcare use. In this study, dyspepsia and
MDE independently predicted frequent medical consulta-
tions while GAD predicted high investigation expendi-
ture. The extent of somatic symptoms is unlikely toexplain the difference, as patients with both GAD and
MDE are associated with frequent physical complaints
that would drive healthcare use.32 Variances in doctor-
patient interaction and cognitive factors may be other
explanations. In particular, more than 70% of GAD
sufferers have excessive health anxiety,33 which may
drive medical decisions into ordering more investiga-
tions. For MDE, medical consultations may be driven by
the distinct distress and impairment in depression, and
increased mental health literacy of patients regarding
depression as an illness.
Our study has several limitations. First, endoscopy was
not done. It is uncertain how strictly applied Rome III
dyspepsia symptom criteria would predict lack of orga-
nicity. However, the subgroup of subjects with peptic
ulcer disease and gastric ulcer is likely to be a small
minority. Our previous endoscopy study in referred
patients with dyspepsia found organicity in less than 10%
of patients.34 The Kalixanda study found no organicity in
77% of uninvestigated dyspepsia cases,15 while a meta-
analysis found positive endoscopy in 20% of dyspeptics,
only 6% in Rome-dened dyspeptics.35 Second, we did a
brief telephone survey instead of a detailed face-to-face
one. However, by avoiding face-to-face contact, telephone
surveys may avoid psychiatric stigma, and facilitate dis-
closure of sensitive information.36 This is critical for the
Chinese for whom disclosing psychological distress may
be culturally inhibited.37 Third, other potentially impor-tant factors associated with dyspepsia were omitted owing
to the need for brevity in a telephone survey, such as
medication use. Fourth, recall bias and cross-sectional
design limited the study of chronology. In particular, our
analysis on order of onset and prevalence of dyspepsia
had a clear limitation in assuming future onset of
dyspepsia for those with only mental disorders cur-
rently, but such ‘comorbidity ’ was not inevitable. The
order of onset thus designated was limited by this
assumption and any implications on causality need to
be studied more rigorously in future prospective com-munity studies. Fifth, the study was underpowered for
multivariate analysis for variables associated with psy-
chiatric comorbidity and healthcare utilisation in the
dyspepsia subgroup. Future population-based studies
using larger samples may endeavour to explore this
area. Lastly, we assessed current prevalence of dyspepsia
and 12-month prevalence of GAD and MDE so as to
render the ndings comparable to other community
surveys. It should be noted that this approach may
somewhat inate the prevalence gures for the mental
disorders relative to that of dyspepsia.In conclusion, we found Rome III dyspepsia to be
common and strongly associated with MDE and GAD as
mental disorders, with substantial impact on healthcare
use in the community. The implications are that one,
mental disorders should be routinely screened in assess-
ing dyspepsia, especially those exhibiting high levels of
healthcare use. Two, clinicians treating dyspepsia with
comorbid GAD or MDE should regard help-seeking
behaviour as a salient part of illness experience. Instead
808 Aliment Pharmacol Ther 2012; 36: 800-810ª 2012 Blackwell Publishing Ltd
A. D. P. Mak et al.
-
8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics
10/11
of routinely discouraging unnecessary consultations or
investigations, holistic and effective approaches in treat-
ing these complexly ill individuals may do their health
better while reducing unnecessary expenses. Collabora-
tive psychosomatic care involving gastroenterologists and
mental health professionals may address this. Lastly, pro-
spective research is needed on courses of dyspepsia and
comorbid mental disorders, as well as translational
research in such light.
ACKNOWLEDGEMENTS
Declaration of personal interests: Dr Arthur Mak is sup-
ported by an educational grant of Pzer Pharmaceutical.
Dr Justin Wu is supported by research funds of Depart-
ment of Medicine & Therapeutics and educational grant
of Pzer Pharmaceutical. Dr Sing Lee received educa-
tional grants on mental health education from Pzer
Pharmaceuticals, GlaxoSmithkline, Wyeth Pharmaceuti-
cals and Johnson & Johnson Pharmaceuticals. Declara-
tion of funding interests: None.
SUPPORTING INFORMATION
Additional Supporting Information may be found in theonline version of this article:
Appendix S1. Comparison of study sample composi-
tion and 2008 Hong Kong Census population data, and
weighting factor applied.
Please note: Wiley-Blackwell are not responsible for
the content or functionality of any supporting materials
supplied by the authors. Any queries (other than missing
material) should be directed to the corresponding author
for the article.
REFERENCES
1. Agreus L, Borgquist L. The cost of gastro-oesophageal reux disease,dyspepsia and peptic ulcer disease inSweden. Pharmacoeconomics 2002; 20:347 – 55.
2. El-Serag HB, Talley NJ. Systemicreview: the prevalence and clinicalcourse of functional dyspepsia.
Aliment Pharmacol Ther 2004; 19:643 – 54.
3. Tack J, Talley NJ, Camilleri M, et al.
Functional gastroduodenal disorders.Gastroenterology 2006; 130: 1466 – 79.
4. Henningsen P, Zimmermann T, SattelH. Medically unexplained physicalsymptoms, anxiety, and depression: ameta-analytic review. Psychosom Med 2003; 65 : 528 – 33.
5. Hasin DS, Goodwin RD, Stinson FS,Grant BF. Epidemiology of majordepressive disorder: results from theNational Epidemiologic Survey onAlcoholism and Related Conditions.
Arch Gen Psychiatry 2005; 62 : 1097 – 106.
6. Carter RM, Wittchen HU, Pster H,
Kessler RC. One-year prevalence of subthreshold and threshold DSM-IVgeneralized anxiety disorder in anationally representative sample.Depress Anxiety 2001; 13: 78 – 88.
7. Van Oudenhove L, Vandenberghe J,Geeraerts B, et al. Relationship betweenanxiety and gastric sensorimotorfunction in functional dyspepsia.Psychosom Med 2007; 69 : 455 – 63.
8. Lehoux CP, Abbott FV. Pain, sensory function, and neurogenic inammatory response in young women with low
mood. J Psychosom Res 2011; 70:241 – 9.
9. de Medeiros MT, Carvalho AF, DeOliveira Lima JW, Dos Santos AA, deOliveira RB, Nobre ESMA. Impact of depressive symptoms on visceralsensitivity among patients with differentsubtypes of irritable bowel syndrome. J Nerv Ment Dis 2008; 196 : 711 – 4.
10. Blomhoff S, Spetalen S, Jacobsen MB,Malt UF. Phobic anxiety changes the
function of brain-gut axis in irritablebowel syndrome. Psychosom Med 2001;63: 959 – 65.
11. Haug TT, Svebak S, Wilhelmsen I,Berstad A, Ursin H. Psychologicalfactors and somatic symptoms infunctional dyspepsia. A comparisonwith duodenal ulcer and healthy controls. J Psychosom Res 1994; 38:281 – 91.
12. Koloski NA, Talley NJ, Boyce PM.Does psychological distress modulatefunctional gastrointestinal symptomsand health care seeking? A prospective,community Cohort study. Am J
Gastroenterol 2003; 98 : 789 –
97.13. Pajala M, Heikkinen M, Hintikka J. A
prospective 1-year follow-up study inpatients with functional or organicdyspepsia: changes in gastrointestinalsymptoms, mental distress and fear of serious illness. Aliment Pharmacol Ther 2006; 24 : 1241 – 6.
14. Hu WH, Wong WM, Lam CL, et al.Anxiety but not depression determineshealth care-seeking behaviour inChinese patients with dyspepsia andirritable bowel syndrome: a population-
based study. Aliment Pharmacol Ther 2002; 16 : 2081 – 8.
15. Aro P, Talley NJ, Ronkainen J, et al.Anxiety is associated withuninvestigated and functional dyspepsia(Rome III criteria) in a Swedishpopulation-based study.Gastroenterology 2009; 137 : 94 – 100.
16. American Psychiatric Association.Diagnostic and Statistical Manual for
Mental Disorders, 4th edn. Text
Revision. Washington, DC: AmericanPsychiatric Association, 2000.
17. So EK, Kam I, Leung CM, Chung D,Liu Z, Fong S. The Chinese-bilingualSCID-I/P Project: stage 1 - reliability for mood disorders and schizophrenia.Hong Kong J Psychiatry 2003; 13 :7 – 18.
18. Tse AW, Lai LH, Lee CC, et al.Validation of self-administratedquestionnaire for psychiatric disordersin patients with functional dyspepsia. J Neurogastroenterol Motil 2010; 16 : 52 – 60.
19. Eaton WW, Kramer M, Anthony JC,
Drman A, Shapiro S, Locke BZ.Conceptual and methodologicalproblems in estimation of the incidenceof mental disorders from eld survey data. In: Copper BH, Helgason T, eds.Epidemiology and the Prevention of Survey Data. London: Routledge, 1989;108 – 27.
20. Census & Statistics Department tGotH.Hong Kong Statistics. Hong Kong 2009 .Available at: http://www.statistics.gov.hk/pub/B10100032009AN09B0700.pdf.Accessed December 1, 2011.
Aliment Pharmacol Ther 2012; 36: 800-810 809ª 2012 Blackwell Publishing Ltd
Community study on dyspepsia, depression and anxiety
-
8/20/2019 Mak Et Al-2012-Alimentary Pharmacology & Therapeutics
11/11
21. Functional Dyspepsia Module. Tampa,Florida: Rome Foundation, Inc .Available at: http://www.romecriteria.org/pdfs/DyspepMode.pdf. AccessedDecember 1, 2011.
22. Lee S, Tsang A, Chui H, Kwok K, Cheung E. A community epidemiological survey of generalized anxiety disorder in Hong Kong. Community Ment Health J 2007;
43: 305 –
19.23. Lee S, Tsang A, Kwok K. Twelve-
month prevalence, correlates, andtreatment preference of adults withDSM-IV major depressive episode inHong Kong. J Affect Disord 2007; 98 :129 – 36.
24. Lee S, Tsang A, Lau L, Mak A, Ng KL,Chan DM. Concordance betweentelephone survey classication and face-to-face structured clinical interview inthe diagnosis of generalized anxiety disorder in Hong Kong. J Anxiety Disord 2008; 22 : 1403 – 11.
25. Lee S, Tsang A, Mak A, Lee A, Lau L,
Ng KL. Concordance betweentelephone survey classication andface-to-face interview diagnosis of one-year major depressive episode inHong Kong. J Affect Disord 2010; 126 :155 – 60.
26. Lee S, Wu J, Ma YL, Tsang A, Guo WJ,Sung J. Irritable bowel syndrome is
strongly associated with generalizedanxiety disorder: a community study.
Aliment Pharmacol Ther 2009; 30 :643 – 51.
27. Hsieh FY, Block DA, Larsen MD. Asimple method of sample sizecalculation for linear and logisticregression. Stat Med 1998; 17 : 1623 – 34.
28. Lee S, Guo WJ, Tsang A, et al.
Evidence for the 2008 economic crisisexacerbating depression in Hong Kong.
J Affect Disord 2010; 2 : 125 – 33.29. Holsboer FK, Kunzel HE. Clinical
neuroendocrinology. In: Charney DS,Nestler EJ, eds. Neurobiology of Mental Illness. New York: Oxford University Press, 2004; 155 – 70.
30. Tache Y, Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motorfunction. J Clin Invest 2007; 117 : 33 – 40.
31. Naliboff BD, Mayer M, Fass R, et al.The effect of life stress on symptoms of heartburn. Psychosom Med 2004; 66 :
426 –
34.32. Kroenke K, Jackson JL, Chamberlin J.
Depressive and anxiety disorders inpatients presenting with physicalcomplaints: clinical predictors andoutcome. Am J Med 1997; 103 : 339 – 47.
33. Lee S, Ma YL, Tsang A. A community study of generalized anxiety disorder
with vs. without health anxiety in Hong Kong. J Anxiety Disord 2011; 25: 376 – 80.
34. Sung JJ, Lao WC, Lai MS, et al.Incidence of gastroesophagealmalignancy in patients with dyspepsiain Hong Kong: implications forscreening strategies. Gastrointest Endosc 2001; 54 : 454 – 8.
35. Ford AC, Marwaha A, Lim A,
Moayyedi P. What is the prevalence of clinically signicant endoscopic ndingsin subjects with dyspepsia? Systematicreview and meta-analysis. ClinGastroenterol Hepatol 2010; 8 : 830 – 7.
36. McQueen DV. Comparison of results of personal interview and telephonesurveys of behavior related to risk of AIDS: advantages of telephonetechniques. In: Fowler F, ed. HealthSurvey Research Methods: ConferenceProceedings. Washington, DC:Government Printing Of ce, 1989;247 – 52.
37. Ho DYF, Fu W, Ng SM. Guilt, shame
and embarrassment: revelations of face and self. Culture Psychology 2004;10: 64 – 84.
810 Aliment Pharmacol Ther 2012; 36: 800-810ª 2012 Blackwell Publishing Ltd
A. D. P. Mak et al.